Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027651 (
tumor
)
685,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The concentrations of calcium and magnesium, and of the trace elements iron, copper,
manganese
and zinc were determined in the amputation specimen of a 25-year-old patient with osteosarcoma and compared with the
tumor
-free, normal bone tissue. Not only the concentrations of calcium and magnesium, but also those of the trace elements were significantly higher in the osseous portion of the
tumor
. The periosseous concentrations of trace elements iron, copper and zinc were also significantly higher in the
tumor
than in the normal bone tissue.
...
PMID:[Mineral and trace element determination in human osteosarcoma. Case report]. 659 3
The prelytic adhesion of immune cytolytic thymus-derived lymphocytes to specific antigen-bearing ascites
tumor
target cells has been studied. A new assay was used in which adhesions are permitted to form for 2.5 min; the cells are then dispersed to prevent further adhesion, and the predispersion adhesions are quantitated by subsequent 51Cr release from the
tumor
cells as a result of cytolytic activity of the adhering lymphocytes. There were the following new findings: (a) magnesium is sufficient to support optimal adhesion formation even when EGTA is added to remove contaminating traces of calcium; (b) calcium supports no adhesion formation when traces of contaminating magnesium are removed by pretreating the medium with a chelating ion exchange resin; (c) calcium synergizes with suboptimal magnesium, increasing the apparent adhesion-supporting potency of magnesium 20-fold in the presence of 50 microM calcium; (d) in the presence of optimal magnesium (2--4 mM), calcium has not effect on the properties of the adhesion by any of six criteria; and (e)
manganese
supports adhesion better than magnesium, and strontium is ineffective. A survey of previous literature indicates that these results are remarkably similar to the predominant pattern for nonimmunologic cell adhesion (e.g., fibroblasts) involving cells from a variety of tissues in late embryonic and adult avians and mammals. This suggests that a "magnesium sufficient, calcium insufficient" mechanism may be found among the latter types of cell adhesions when appropriately examined. Moreover, it seems that the present lymphocyte-
tumor
cell adhesion, although evoked by specific receptor-antigen recognition, relies predominantly on mechanisms common to nonimmunologic intercellular adhesion processes.
...
PMID:Immune T lymphocyte to tumor cell adhesion. Magnesium sufficient, calcium insufficient. 676 45
The metabolism of calcium has been investigated in the Ehrlich Ascites
Tumour
Cells (ATC). ATC extrude Ca2+ actively by an energy-dependent mechanism, supported by both respiration and glycolysis. Extrusion takes place even against a very steep concentration gradient (10 mM Ca2+). Cell calcium content is decreased by monovalent cations (Na+,K+ and Li+), which act independently from their metabolic effects. La3+ inhibits ATC Ca2+ extrusion whereas Ruthenium Red slightly decreases cell calcium content. The antibiotic ionophore A 23187 strongly increases ATC Ca2+ level. the metabolism of other divalent cations (Mg2+, Sr2+ and
Mn2+
) has been studied. Mg2+ does not show appreciable changes in the various metabolic conditions tested, while
Mn2+
and Sr2+ behave quite differently from Ca2+, suggesting a different distribution of these cations in ATC. The experimental findings indicate that Ehrlich Ascites
Tumour
Cells regulate their calcium content by mechanisms related to plasma membranes while the size and activity of mitochondrial compartment is of minor importance.
...
PMID:Further observations on calcium and other divalent cations metabolism in intact Ehrlich ascites tumour cells. 678 6
The effects of
manganese
compounds upon the carcinogenicity of alpha Ni3S2 were tested in male Fischer rats. In Experiment I, rats were given i.m. injections of alpha Ni3S2 (2.5 mg) and Mn dust (2.0 mg), singly or in combination. By 100 weeks, sarcomas occurred at the injection site in 0 of 24 rats in the vehicle control group, in 0 of 24 rats that received Mn dust alone, and in 23 of 24 rats that received alpha Ni3S2 alone. Combined administration of alpha Ni3S2 plus Mn dust as a single i.m. injection resulted in sarcomas in 14 of 23 rats (p less than 0.05 versus alpha Ni3S2 alone). In rats that received injections of alpha Ni3S2 in one thigh and Mn dust in the opposite thigh, the sarcoma incidence at the site of alpha Ni3S2 injection was 24 of 24 rats. In Experiment II, rats were given i.m. injections of alpha Ni3S2 (1.2 mg) and Mn compounds (MnS, Mn2O3, MnO2 or MN2(CO)10, in dosages equivalent to 1.0 mg of Mn), singly or in combination. No sarcomas occurred at the injection site in rats that received the vehicle or any of the
manganese
compounds alone. Sarcomas occurred in 13 of 27 rats that received alpha Ni3S2 alone; this sarcoma incidence was not reduced by admixture of any of the Mn compounds. The median
tumor
latent period and the median survival period were significantly longer (p less than 0.05) in rats that received MnS plus alpha Ni3S2, compared with rats that received alpha Ni3S2 alone, suggesting that MnS may have weak anticarcinogenic effect. These experiments demonstrate that inhibition of alpha Ni3S2-carcinogenesis by Mn dust is a local rather than a systemic effect, and that, with the possible exception of MnS, the other
manganese
compounds that were tested are ineffective as inhibitors of alpha Ni3S2-carcinogenesis.
...
PMID:Effects of manganese compounds on carcinogenicity of nickel subsulfide in rats. 683 19
Growth of Ehrlich carcinomas in inbred CBA mice was retarded by im administration of Cu(II)(3,5-diisopropylsalicylate)2 (CuDIPS). CuDIPS is a low molecular weight (mol wt = 503) copper coordination compound that exhibits superoxide dismutase (SOD)-like activity. It has been used as an anti-inflammatory agent and is lipid-soluble. This property enables the compound to penetrate membranes, thus becoming an intracellular O2- scavenger. In the
tumor
system studied, the amounts of both copper- and zinc-containing SOD (CuZnSOD) and
manganese
-containing SOD are reduced. Injection of Orgotein (CuZnSOD from bovine liver) had no significant effect on tumor growth and host survival. When CuDIPS was administered at various doses, reduction in
tumor
size, delay of metastasis, and a significant increase in survival of the hosts were observed.
...
PMID:Antitumor effect of a copper coordination compound with superoxide dismutase-like activity. 694 Oct 42
Antibody raised against S-II, a stimulatory factor of RNA polymerase II from Ehrlich ascites
tumor
cells, inhibited accurate transcription from adenovirus 2 major late promoter in a HeLa cell lysate.
Manganese
prevented accurate transcription, but it was essential for expression of the stimulatory activity of S-II. The results indicate that protein(s) cross-reacting immunologically with S-II in a HeLa cell lysate is essential for accurate transcription of truncated DNA, but the stimulatory activity of this factor(s) is not necessary for accurate transcription of truncated DNA.
...
PMID:Evidence that stimulatory factor(s) of RNA polymerase II participates in accurate transcription in a HeLa cell lysate. 706 45
Distribution profiles of superoxide dismutase isoenzymes in various tissues of rabbits with the Vx-2 carcinoma in the maxillary sinus were compared with those of control rabbits. Copper- and zinc-containing superoxide dismutase (Cu,Zn-SOD) activity in the liver of rabbits decreased significantly 3 weeks after transplantation.
Manganese
-containing superoxide dismutase (Mn-SOD) activity did not decrease significantly within 5 weeks after transplantation. In other tissues from the
tumor
-bearing rabbits, Cu,Zn-SOD and Mn-SOD activities were not changed within 5 weeks. No Mn-SOD activity and low Cu,Zn-SOD activity were detected in the Vx-2 carcinoma. These results suggest that the Vx-2 carcinoma has lost most of its ability to defend against oxygen toxicity and this ability decreased only in the liver of rabbits bearing the Vx-2 carcinoma in the maxillary sinus.
...
PMID:Superoxide dismutase in various tissues from rabbits bearing the Vx-2 carcinoma in the maxillary sinus. 710 16
An endoribonuclease which cleaves only single-stranded RNA has been purified from nucleoli of Ehrlich ascites
tumor
cells. The molecular weight of the ribonuclease is 50,000 to 52,000 as estimated from sedimentation in glycerol density gradients and by gel filtration on Sephadex G-100. The endoribonuclease requires Mg2+ or
Mn2+
(0.2 mM) for optimum activity. Monovalent cations including K+, Na+, and NH+4 are inhibitory. The ribonuclease gave an apparent Km for single-stranded RNA of 30 microM. Using ribohomopolymers, we found that the enzyme could digest single-stranded, poly(C), poly(U), and poly(A) equally well, but would not degrade duplex poly(C) . poly(I) or poly(A) . poly(U). The lack of base specificity was further demonstrated using RNA sequence analysis of partial digest products of yeast 5.8 S RNA. The ribonuclease activity is sensitive to EDTA and N-ethylmaleimide, but is not inhibited by human placental RNase inhibitor. The enzyme makes endonucleolytic cleavages which generate 5'-phosphate-terminated oligonucleotides.
...
PMID:Isolation and characterization of a single-stranded specific endoribonuclease from Ehrlich cell nucleoli. 714 16
A phase I clinical trial was performed to detect adverse reactions in far advanced cancer patients treated with a unique specific cancer immunotherapy. The vaccines consisted of autologous
tumor
cell membranes and
manganese
phosphate gel. From 133 patients admitted into the trial, 95 vaccine batches were made. No batch was toxic in animals. One batch was bacteriologically contaminated. Sufficient patients survived or complied to receive 32 complete and 23 partial courses for a total of 707 SC and ID injections. Minor swelling and occasional minimal pain occurred at injection sites. There were two possible vaccine-related systemic reactions but no evidence of
tumor
transplantation,
tumor
acceleration, sepsis or autoimmune disease. Subjective and objective improvement occurred in a number of patients. The vaccines are safe. Their efficacy must be determined. The value of ID vaccine skin testing and the unexpectedly little bacteriological contamination require further study.
...
PMID:Autologous anticancer antigen preparation for specific immunotherapy in advanced cancer patients. A phase I clinical trial. 715 75
Adenylosuccinate synthetase (IMP:L-aspartate ligase (GDP-forming), EC 6.3.4.4) was purified about 750-fold to a homogeneous state from Yoshida sarcoma ascites
tumor
cells. A yield of 38% purified enzyme was achieved by a procedure including affinity chromatography on hadacidin-Sepharose 4B. Ultracentrifugal analyses showed that the molecular weight of the native enzyme was 102 000 with an s20,w value of 4.5 and that the molecular weight in 6 M guanidine-HCl was 47 000. These values indicate that the native enzyme is composed of two subunits. The isoelectric point was determined to be 5.9 by isoelectric focusing. The optimum pH for activity was 6.8-7.0. The Km values for IMP, aspartate and GTP were calculated to be 4.1, 9.8 and 0.7 . 10(-4) M, respectively. The antibiotic, hadacidin was strongly inhibitory, causing competitive inhibition with respect to aspartate with a Ki value of 2.5 . 10(-6) M. Nucleoside mono- and diphosphate also inhibited the enzyme activity, but their inhibitions were not apparently specific. The purified enzyme showed full activity in the presence of Mg2+, and Mg2+ could be partially replaced by
Mn2+
, Co2+, Ca2+ or Cu2+. Divalent metal ions, such as Cd2+, Pb2+, Zn2+, Cu2+ and
Mn2+
, interfered with the activity by antagonizing Mg2+. Hg2+ or PCMB inactivated the enzyme, suggesting that an SH-group may be important for activity.
...
PMID:Purification and properties of adenylosuccinate synthetase from Yoshida sarcoma ascites tumor cells. 721 42
<< Previous
1
2
3
4
5
6
7
8
9
10